These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 7854772
21. High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. Int J Gynecol Cancer; 2006; 16(4):1529-35. PubMed ID: 16884361 [Abstract] [Full Text] [Related]
22. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary. Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I. Gynecol Oncol; 1998 Jan; 68(1):35-7. PubMed ID: 9454657 [Abstract] [Full Text] [Related]
23. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I. Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350 [Abstract] [Full Text] [Related]
36. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients]. Lawicki S, Czygier M, Omyła J, Szmitkowski M. Pol Arch Med Wewn; 2006 Aug; 116(2):749-55. PubMed ID: 17424919 [Abstract] [Full Text] [Related]
39. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients]. Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M. Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612 [Abstract] [Full Text] [Related]